Ibn Sina Pharmaceutical Industry’s consolidated earnings per share (EPS) rose 8.2 per cent year on year to Tk7.66 in the July–September quarter of FY27, from Tk7.08 in the same period a year earlier.
The company’s consolidated net operating cash flow per share fell sharply to Tk0.43 from Tk5.46 over the same period, according to its unaudited financial statements approved by the board on Sunday.
Consolidated net asset value per share (NAVPS) stood at Tk152.22 at the end of September, compared with Tk144.56 at the end of June.
On a standalone basis, EPS was Tk7.72 and net operating cash flow per share was Tk0.22 for the quarter. Standalone NAVPS stood at Tk152.40 at the end of September.
The board approved the unaudited first-quarter financial statements at its 343rd meeting on Sunday.
